Shearman & Sterling advised the underwriters in the offering. Mazanti advised Y-mAbs Therapeutics.r Y-mAbs Therapeutics, Inc. executed its 2,804,878 shares of common stock at a public offering...
Y-mAbs Therapeutics’ $115 Million Follow-On Public Offering
Waldencast Acquisition’s $345 Million Initial Public Offering
Shearman & Sterling advised Credit Suisse and J.P. Morgan as joint book-running managers on the IPO. Waldencast Acquisition Corp., a special-purpose acquisition company, executed its initial...